Melanie Whittington

Melanie (Mel) Whittington is a Managing Director and Head of the Center for Pharmacoeconomics at Leerink Partners, where she leads efforts to demonstrate the societal impacts of healthcare treatments in the United States. As a thought leader in health economics, Dr. Whittington develops cost-effectiveness analyses of both in-development and approved pharmaceuticals from a societal perspective and offers guidance on key components and novel methodologies.

Prior to joining MEDACorp in 2024, Dr. Whittington was the Managing Director and Founder of Valusphere, a health economic consultancy that developed economic evaluations, advised on value demonstration, and provided training to value assessment stakeholders. Prior to Valusphere, Dr. Whittington was the Director of Health Economics at the Institute for Clinical and Economic Review, where she led the design and development of economic evaluations, and was faculty within the School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. Dr. Whittington is a Senior Fellow within the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center and has published more than 70 articles.

Dr. Whittington earned a BS in Biological Sciences from the University of Missouri, an MS in Health Sciences from Western Illinois University, and a PhD in Health Services Research from the University of Colorado Anschutz Medical Campus.